Meeting Banner
Abstract #3099

Magnetic resonance spectroscopic imaging of hyperpolarized [1-13C]pyruvate in glioblastoma: a promising tool for investigating tumor metabolism and heterogeneity.

Fulvio Zaccagna1, James T Grist1, Mary A. McLean2, Charlie J Daniels1, Frank Riemer1, Joshua Kaggie1, Surrin Deen1, Ramona Woitek1, Rolf F Schulte 3, Kieren Allinson4, Anita Chhabra 5, Marie-Christine Laurent1, Amy J Frary1, Tomasz Matys1, Ilse Patterson6, Bruno Do Carmo6, Stephan Urpsrung 1, Ian Wilkinson7, Bristi Basu8, Colin Watts9, Stephen J Price9, Sarah Jefferies8, Jonathan H Gillard1, Martin J Graves1, Kevin M Brindle2, and Ferdia A Gallagher1

1Department of Radiology, University of Cambridge, Cambridge, United Kingdom, 2Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom, 3GE Global Research, Munich, Germany, 4Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom, 5Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom, 6Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom, 7Department of Medicine, University of Cambridge, Cambridge, United Kingdom, 8Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom, 9Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom

Glioblastomas (GBM) are characterized by diffuse infiltration, a high level of intratumoral and intertumoral heterogeneity and a very poor prognosis. Characterising tumor heterogeneity in vivo may improve diagnosis, therapy planning and treatment assessment. Dissolution dynamic nuclear polarization (DNP) is a novel technique that allows dynamic and non-invasive assessment of the metabolism of hyperpolarized (HP) 13C-labelled molecules in vivo, such as the preferential exchange of [1-13C]pyruvate to [1-13C]lactate within tumors (Warburg effect). In this study we explore metabolic reprogramming within glioblastoma (GBM) and its microenvironment using HP [1-13C]pyruvate to demonstrate the heterogeneity of pyruvate’s metabolic fate.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords